This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Uncategorised Disease
  • /
  • Metastatic non-small-cell lung cancer (NSCLC): ESM...

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Read time: 1 mins
Last updated:1st Aug 2014

The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Primary lung cancer is the most common malignancy after non-melanocytic skin cancer, and the leading cause of human cancer deaths worldwide. These guidelines focus on diagnosis and personalised medicine, staging and risk assessment and management of advanced/metastatic NSCLC including follow-up.


Read full guideline